Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Cow's-milk protein allergy

Paediatrics and child health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Acute anaphylaxis

Sudden airway, breathing or circulation compromise after milk exposure is anaphylaxis; skin changes may be absent. Repetitive vomiting with pallor, floppiness or cardiovascular compromise can also be severe allergy.

Action: Give intramuscular adrenaline 1 mg/mL into the anterolateral thigh at 0.01 mL/kg, maximum 0.5 mL, call 999, position according to physiology and repeat after 5 minutes if airway, breathing or circulation problems persist. Begin age-appropriate life support if needed. Observe in an appropriate setting and refer for specialist allergy assessment, emergency plan and devices.

Synopsis

Recognise immediate and delayed cow's-milk protein allergy, distinguish it from lactose intolerance and common infant symptoms, confirm diagnosis with the appropriate test or elimination-reintroduction sequence, prescribe nutritionally complete substitutes and prevent unsafe restriction or home challenge.

  • Cow's-milk protein allergy is immune mediated. Lactose intolerance is not milk allergy and is uncommon as a primary disorder in young infants; lactose-free formula still contains cow's-milk protein.
  • IgE-mediated allergy usually produces reproducible symptoms within minutes to 2 hours: urticaria, angioedema, wheeze, cough, vomiting, hypotension or collapse.
  • Non-IgE allergy is delayed over hours to days and may cause eczema, diarrhoea, constipation, blood or mucus in stool, vomiting, reflux-like distress or faltering growth; these symptoms are nonspecific.
  • First-line diagnosis is an allergy-focused history covering timing, dose, reproducibility, systems involved, feeding, growth, eczema and previous treatment. Do not order indiscriminate food panels.
  • For suspected IgE allergy, skin-prick testing or serum specific IgE supports diagnosis only when interpreted against history. Test magnitude does not predict future reaction severity.
  • For mild-to-moderate suspected non-IgE allergy, use a 2–6 week cow's-milk protein elimination followed by planned reintroduction. Improvement without relapse on reintroduction does not confirm allergy.
  • A medically supervised oral food challenge is the reference standard when diagnosis remains uncertain or specialist reassessment of tolerance is needed; it is not undertaken in primary care for suspected immediate allergy.
  • Continue breastfeeding. If symptoms occur through breast milk, a time-limited maternal dairy elimination may be tried with dietitian support, calcium and vitamin D, followed by reintroduction to confirm causality.
  • For formula-fed infants, an extensively hydrolysed formula is first line for most mild-to-moderate cases. Use amino-acid formula for severe disease, anaphylaxis, significant faltering or failure of an adequate hydrolysate trial with specialist input.
  • Goat's- and sheep's-milk formulas cross-react and are unsuitable. Partially hydrolysed and comfort formulas do not treat allergy; soy is generally avoided under 6 months and needs individual assessment thereafter.
  • A home milk ladder is for selected confirmed non-IgE allergy under clinician or dietitian direction. It is unsafe after anaphylaxis or other significant immediate reactions unless the allergy team explicitly plans it.
  • Review the diagnosis and test for tolerance. Unnecessary long-term exclusion impairs nutrition, increases cost and may increase anxiety around food.

Key red flags

Stridor, wheeze, persistent cough, tongue swelling, collapse or altered responsiveness after milk is anaphylaxis until proved otherwise.

Poor perfusion, lethargy or repetitive vomiting 1–4 hours after ingestion may represent food protein-induced enterocolitis and requires urgent assessment.

Bilious or projectile vomiting, abdominal distension, haematemesis or substantial rectal bleeding requires evaluation for surgical, infectious or inflammatory disease.

Faltering growth, hypoalbuminaemia, iron deficiency or extensive enteropathy needs paediatric and dietetic assessment and may require amino-acid formula.

Respiratory symptoms during a feed may indicate aspiration rather than allergy; assess swallowing and cardiorespiratory state.

Multiple food exclusions, severe eczema, parental fear or lack of an affordable replacement risks malnutrition and needs early specialist support.

Investigation priorities

01
First-line: allergy-focused historyFirst stepFirst line

Estimate mechanism and pre-test probability before testing or elimination.

02
Reference standard: supervised oral food challengeReference standard

Resolve diagnostic uncertainty or reassess tolerance in a controlled setting.

Management branches

ImmediateTreat and refer IgE allergy

Milk causes rapid objective skin, respiratory, gastrointestinal or circulatory symptoms.

  1. Treat anaphylaxis immediately with intramuscular adrenaline and emergency services.
  2. Avoid milk, obtain allergy testing through an appropriately competent service and provide a written emergency plan.
  3. Arrange dietitian review and specialist-supervised challenge or tolerance reassessment according to risk.

Key medicines

Adrenaline 1 mg/mL intramuscular injectionSuspected anaphylaxis: 0.01 mL/kg intramuscularly into the anterolateral thigh, maximum 0.5 mL; repeat after 5 minutes if airway, breathing or circulation problems persist.Call 999, do not delay for antihistamine, and use the intramuscular route. Autoinjector doses follow age or weight and the prescribed emergency plan; arrange observation and specialist follow-up.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE CG116 food allergy recommendationsAllergy-focused history, IgE testing, non-IgE elimination-reintroduction and referral criteria.
  • BSACI guideline for cow's-milk allergyUK specialist diagnostic, formula, elimination and tolerance-management guidance.
  • Resuscitation Council UK emergency treatment of anaphylaxisIntramuscular adrenaline, positioning and repeat-dose emergency guidance.
  • NHS food allergySymptoms, emergency recognition and public-facing allergy advice.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom